Drugs in Palliative Care
Andrew Dickman
There are few fields of healthcare which do not, at some point, involve
caring for the dying patient. Dying is the one clinical process that all people
will face, yet the evidence base to inform how we look after our patients
is woefully inadequate. This is not to say the medicines at our disposal
are without evidence base; on the contrary, many have been rigorously
evaluated in randomized clinical trials. However, such studies are usually
conducted in patient populations with a better prognosis and performance
status than those nearing the end of life. Patients under the care of generic
and specialist palliative care services are rarely eligible for such studies and
the clinical outcome measures used are often of limited utility in the palliative
care context.
caring for the dying patient. Dying is the one clinical process that all people
will face, yet the evidence base to inform how we look after our patients
is woefully inadequate. This is not to say the medicines at our disposal
are without evidence base; on the contrary, many have been rigorously
evaluated in randomized clinical trials. However, such studies are usually
conducted in patient populations with a better prognosis and performance
status than those nearing the end of life. Patients under the care of generic
and specialist palliative care services are rarely eligible for such studies and
the clinical outcome measures used are often of limited utility in the palliative
care context.
Kategorien:
Jahr:
2023
Auflage:
3rd
Verlag:
Oxford University Press
Sprache:
english
Seiten:
753
ISBN 10:
0198746407
ISBN 13:
9780198746409
Datei:
PDF, 11.59 MB
IPFS:
,
english, 2023